Last Updated: June 7, 2026

DICYCLOMINE Drug Patent Profile

Name: DICYCLOMINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Dicyclomine patents expire, and when can generic versions of Dicyclomine launch?

Dicyclomine is a drug marketed by Annora Pharma, Aurobindo Pharma Usa, Corepharma, Lannett, Pioneer Pharms, Prinston Inc, Rising, Sun Pharm Industries, Twi Pharms, Watson Labs, West Ward, Am Regent, Dr Reddys, Fosun Pharma, Fresenius Kabi Usa, Hikma, Nexus, Praxgen Pharms, Renew Pharms, Slate Run Pharma, Somerset Theraps Llc, Alpharma Us Pharms, Novitium Pharma, Ph Health, Bionpharma, Hikma Pharms, and Rubicon Research. and is included in forty-two NDAs.

The generic ingredient in DICYCLOMINE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dicyclomine

A generic version of DICYCLOMINE was approved as dicyclomine hydrochloride by WATSON LABS on June 19^th, 1986.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for DICYCLOMINE?
What are the global sales for DICYCLOMINE?
What is Average Wholesale Price for DICYCLOMINE?

Summary for DICYCLOMINE

US Patents:	0
Applicants:	27
NDAs:	42
Drug Prices:	Drug price information for DICYCLOMINE
Drug Sales Revenues:	Drug sales revenues for DICYCLOMINE
DailyMed Link:	DICYCLOMINE at DailyMed

Drug patent expirations by year for DICYCLOMINE

US Patents and Regulatory Information for DICYCLOMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	084361-001	Feb 6, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma Pharms	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	040161-001	Oct 1, 1996	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Annora Pharma	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	217566-001	May 7, 2024	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Lannett	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	040230-001	Feb 26, 1999	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma Usa	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	040317-001	Sep 7, 1999	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Annora Pharma	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	CAPSULE;ORAL	218018-001	Jul 1, 2024	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.